Ancora Advisors LLC Buys 4,791 Shares of Agilent Technologies, Inc. $A

Key Points

• Ancora Advisors LLC increased its stake in Agilent Technologies by 33.6% in the first quarter, holding 19,063 shares valued at approximately $2.23 million.
• Agilent Technologies reported earnings of $1.37 per share for its latest quarter, matching analyst expectations, and a revenue increase of 10.1% year-over-year.
• Analysts have set a consensus price target of $139.25 for Agilent Technologies, with ratings ranging from "moderate buy" to "hold" among nine analysts.

Ancora Advisors LLC increased its stake in Agilent Technologies, Inc. (NYSE:A - Free Report) by 33.6% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 19,063 shares of the medical research company's stock after purchasing an additional 4,791 shares during the period. Ancora Advisors LLC's holdings in Agilent Technologies were worth $2,230,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of A. Valeo Financial Advisors LLC boosted its position in Agilent Technologies by 3.0% in the first quarter. Valeo Financial Advisors LLC now owns 3,449 shares of the medical research company's stock valued at $403,000 after buying an additional 102 shares in the last quarter. Cary Street Partners Financial LLC grew its holdings in shares of Agilent Technologies by 2.9% during the first quarter. Cary Street Partners Financial LLC now owns 3,688 shares of the medical research company's stock worth $431,000 after purchasing an additional 103 shares during the last quarter. Western Pacific Wealth Management LP increased its stake in shares of Agilent Technologies by 15.2% in the first quarter. Western Pacific Wealth Management LP now owns 873 shares of the medical research company's stock valued at $102,000 after buying an additional 115 shares during the period. Bartlett & CO. Wealth Management LLC raised its holdings in Agilent Technologies by 5.1% in the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 2,406 shares of the medical research company's stock valued at $281,000 after buying an additional 116 shares during the last quarter. Finally, Brighton Jones LLC boosted its position in Agilent Technologies by 2.6% during the 1st quarter. Brighton Jones LLC now owns 4,784 shares of the medical research company's stock worth $560,000 after buying an additional 121 shares during the period.

Insider Buying and Selling at Agilent Technologies

In related news, CEO Padraig Mcdonnell sold 1,508 shares of the business's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total value of $177,099.52. Following the sale, the chief executive officer owned 37,448 shares in the company, valued at approximately $4,397,893.12. The trade was a 3.87% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.

Analysts Set New Price Targets

Several analysts recently weighed in on A shares. JPMorgan Chase & Co. reduced their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a research note on Thursday, May 29th. UBS Group lowered their price objective on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating for the company in a research report on Thursday, May 29th. Wall Street Zen lowered shares of Agilent Technologies from a "buy" rating to a "hold" rating in a report on Friday. Barclays reaffirmed an "equal weight" rating and issued a $125.00 price target on shares of Agilent Technologies in a research report on Friday, August 29th. Finally, Evercore ISI dropped their price target on shares of Agilent Technologies from $130.00 to $128.00 and set an "in-line" rating on the stock in a research report on Thursday, August 28th. Six equities research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company's stock. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $139.25.

Agilent Technologies Trading Down 1.4%

A traded down $1.76 during midday trading on Tuesday, reaching $126.37. 1,455,885 shares of the company's stock traded hands, compared to its average volume of 1,959,003. The firm has a fifty day moving average of $119.42 and a two-hundred day moving average of $116.00. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $153.84. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The stock has a market capitalization of $35.83 billion, a price-to-earnings ratio of 29.66, a P/E/G ratio of 4.00 and a beta of 1.24.

Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, August 27th. The medical research company reported $1.37 earnings per share for the quarter, hitting analysts' consensus estimates of $1.37. Agilent Technologies had a net margin of 17.97% and a return on equity of 25.51%. The business had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.67 billion. During the same quarter in the prior year, the company earned $1.32 earnings per share. The business's revenue was up 10.1% compared to the same quarter last year. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. On average, equities analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.